Updates are available Correction dated 2024-07-28

Article History

Received: 8 January 2024

Revised: 23 March 2024

Accepted: 26 March 2024

First Online: 29 April 2024

Change Date: 28 July 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00415-024-12491-1

Declarations

:

: Camilla Wohnrade received travel compensations from ITF Pharma GmbH outside the submitted work. Tabea Seeliger received financial support for conference attendance fees by Abbvie, honoraria for preparation of a manuscript by Springer and a research grant by Novartis Pharma GmbH outside the submitted work. Stefan Gingele received research support from Alnylam Pharmaceuticals, CSL Behring, Else Kröner Fresenius Foundation, Deutsche Forschungsgemeinschaft and Hannover Biomedical Research School (HBRS) and consulting and/or speaker honoraria from Alexion, Alnylam Pharmaceuticals, AstraZeneca, GSK, Pfizer and Merck all outside the submitted work. Bogdan Bjelica received travel compensations from ITF pharma GmbH outside the submitted work. Thomas Skripuletz reports honoraria for lectures and travel expenses for attending meetings from Alexion, Alnylam Pharmaceuticals, argenx, Bayer Vital, Biogen, Celgene, Centogene, CSL Behring, Euroimmun, Grifols, Hexal AG, Janssen-Cilag, Merck Serono, Novartis, Pfizer, Roche, Sanofi, Siemens, Swedish Orphan Biovitrum, Teva, Viatris. His research is supported by the German Ministry for Education and Research (BMBF), Bristol-Myers Squibb Foundation for Immuno-Oncology, Claudia von Schilling Foundation for Breast Cancer Research, Else Kröner Fresenius Foundation, Hannover Biomedical Research School (HBRS), Alnylam Pharmaceuticals, CSL Behring, Novartis, Sanofi Genzyme, and VHV Foundation. Susanne Petri received honoraria as a speaker/consultant from Biogen GmbH, Roche, Novartis, Teva, Cytokinetics Inc., Desitin, Italfarmaco, Zambon, Amylyx; and grants from DGM e.V, Federal Ministry of Education and Research, German Israeli Foundation for Scientific Research and Development, EU Joint Programme for Neurodegenerative Disease Research outside the submitted work.

: This investigation was approved by the Ethics Committee of Hannover Medical School (no. 8172-BO-K-2018 and no. 6269 2018) and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: All participants gave their written informed consent prior to their inclusion in the study.